Erika B-Cure Laser Ltd (TLV:BCUR)

Market Cap	21.46M
Revenue (ttm)	37.96M
Net Income (ttm)	-9.47M
Shares Out	104.17M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	156,109
Average Volume	117,842
Open	21.00
Previous Close	21.00
Day's Range	20.50 - 21.60
52-Week Range	16.90 - 40.00
Beta	1.52
RSI	43.98
Earnings Date	Aug 28, 2025

About Erika B-Cure Laser

Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic problems, diabetic wounds, and difficulties in healing and mucositis. The company also provides B-Cure Laser Sport, a home device for treating injuries and ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 44
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: BCUR

Financial Performance

In 2024, Erika B-Cure Laser's revenue was 37.96 million, an increase of 27.03% compared to the previous year's 29.88 million. Losses were -9.47 million, -50.73% less than in 2023.